It is something of a Holy Grail for many European entrepreneurs with plans to export. The US market is vast, potentially lucrative, but tough
And when their products require US Food and Drug Administration (FDA) approval, it gets even tougher.
It is a familiar situation for Swedish medical device company, Timesulin whose product – a smart replacement cap for insulin pens displaying the time since the last insulin injection was administered – helps diabetes patients manage their condition more effectively.
Image: Insulin type syringe ready for injection. Doctors view. Deutsch: eine Insulinspritze, bereit für die Injektion. Aus der Sichtweise des Arztes. (Photo credit: Wikipedia)
